Company: RGNT
Filing Date: 2025-03-11
Form Type: F-1
Source: 0001213900-25-022350
Chunk: 72

Company: REGENTIS BIOMATERIALS LTD.
Filing Date: 2025-03-11
Form: F-1
Chunk 72
---
 or
above the initial public offering price. Some of the factors that may cause the market price of our Ordinary Shares to fluctuate include:

| ● | delays or setbacks in the             
 ongoing commercialization of GelrinC; |

| ● | the success of existing                      
 or new competitive products or technologies; |

| ● | regulatory or legal developments          
 in the United States and other countries; |

| ● | developments or disputes                                                    
 concerning patent applications, issued patents or other proprietary rights; |

| ● | the recruitment or departure 
 of key personnel;            |

| ● | the commencement of litigation; |

<div align='center'>46</div>

| ● | actual or anticipated changes         
 in estimates as to financial results; |

| ● | announcement or expectation      
 of additional financing efforts; |

| ● | sales of our Ordinary Shares               
 by us, our insiders or other shareholders; |

| ● | expiration of market standoff 
 or lock-up agreements;        |

| ● | variations in our financial                                           
 results or those of companies that are perceived to be similar to us; |

| ● | changes in estimates or                                                
 recommendations by securities analysts, if any, that cover our shares; |

| ● | changes in the structure        
 of health care payment systems; |

| ● | market conditions in the 
 medical device sectors;  |

| ● | the seasonality of our 
 business;              |

| ● | an increase in the rate                                               
 of returns of our GelrinC implants or an increase in warranty claims; |

| ● | the impact of any resurgence                                              
 of COVID-19 or other pandemics on the performance of elective procedures; |

| ● | general economic, industry 
 and market conditions; and |

| ● | the other factors described 
 in this “Risk Factors.”     |

In recent years, the stock
market in general, and the market for medical device companies in particular, has experienced significant price and volume fluctuations
that have often been unrelated or disproportionate to changes in the operating performance of the companies whose stock is experiencing
those price and volume fluctuations. Further, the stock market in general has been highly volatile due to recent geopolitical events
across the world. Broad market and industry factors may seriously affect the market price of our Ordinary Shares, regardless of our actual
operating performance. These fluctuations may be even more pronounced in the trading market for our shares shortly following this offering.
Following periods of such volatility in the market price of a company’s securities, securities class action litigation has often
been brought against that